Skip to main content

GSA CAPITAL PARTNERS LLP

Position in NKTR — Nektar Therapeutics

CIK 1362033 LONDON, X0

Position in NKTR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,122,544
-$412,221 QoQ
Shares Held
16,080
-24.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#117
of 239 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. NKTR ranks #30 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,122,544 16,080
2026-03-31 $1,534,765 21,331
2025-12-31 $977,259 23,114
2024-09-30 $278,518 214,245
2024-06-30 $1,154,369 930,943
2024-03-31 $1,850,611 1,989,905
2023-12-31 $2,943,242 5,255,790
2023-09-30 $1,104,646 1,841,078
2023-06-30 $103,523 178,489
2023-03-31 $126,254 180,363
2022-12-31 $1,457,779 645,035
2022-09-30 $189,718 59,287
2022-06-30 $153,618 40,426
2021-12-31 $142,219 10,527
2021-09-30 $405,590 22,583
2021-06-30 $1,504,228 87,659
2020-09-30 $496,190 29,909